缓解药物发现中的分子聚合与可解释AI的预测洞察力
Hunter Sturm1, Jonas Teufel2, Kaitlin A Isfeld1
1University of Manitoba, Chemistry, CANADA.
Angewandte Chemie (International ed. in English)
|May 19, 2025
概括
我们开发了一种多通道图表注意网络 (MEGAN),一种可解释的AI (xAI) 模型,用于识别小合聚合分子 (SCAM). 这种方法减少了药物发现中的假阳性,加速了更好的分子的识别.
科学领域:
- 人工智能的人工智能
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 小合聚合分子 (SCAMs) 在高通量查 (HTS) 中引起假阳性.
- 识别和缓解SCAM对于有效的药物发现至关重要.
- 当前的方法与化学上具有反直观的聚合特性作斗争.
研究的目的:
- 应用一个新的可解释AI (xAI) 模型,MEGAN,用于SCAM识别.
- 利用xAI来理解和设计具有改变聚合性质的分子.
- 为了减少药物发现查管道中的错误阳性.
主要方法:
- 开发和应用一个多道图表注意力网络 (MEGAN).
- 使用可解释的AI (xAI) 进行分子性质分类.
- 基于xAI洞察力生成分子反事实.
- 对MEGAN预测和反事实的实验验验证.
主要成果:
- 梅根成功发现了骗局,解决了药物发现的关键挑战.
- 通过xAI的洞察,可以设计出具有修改聚合行为的替代化合物.
- 实验验证证证实了该模型的预测准确性和反事实的实用性.
- 通过微小的结构修改,证明了改变聚合性能的能力.
结论:
- 作为一个xAI模型的MEGAN有效地识别出 SCAM,并减少 HTS.中的错误阳性.
- xAI为设计改进的候选药物提供了宝贵的见解.
- 整合这种方法加速了可行的分子的发现.
相关概念视频
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Structure-Activity Relationships and Drug Design
469
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
469
Agonism and Antagonism: Quantification
286
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
286


